Management Consulting

Commercial Strategy and Go-to-Market Model

In-depth market intelligence for your business

With a full team of global specialists, you’ll get a granular view of market intelligence, research and trends. Receive in-depth, actionable insights on all areas of your business, including revenue, sales volume, product mix, supply chain, distribution channels, R&D, and manufacturing.

Tailored strategy, planning, and execution

The successful realization of commercial potential requires the combination of a precise strategy with a robust go-to-market model. At Alira Health, our team of global specialists designs both specifically for your business.

From the beginning, we’ll help you define strategic goals, identify critical success factors needed to achieve those goals, and plan the commercial and scientific actions to realize them.

We’ll help you determine which organizational capabilities will be critical to your success, and insight on whether those should be developed internally or accessed through third-party partnerships. Our extensive, world-wide network of healthcare, pharma, and MedTech organizations helps us connect you with the right partners.

Why choose Alira Health?

With Alira Health as your partner, you will benefit from:

  • Market-leading and global specialists with diverse industry and advisory experience
  • Our nuanced understanding of both the customer and competitive space to deliver strategic guidance and go-to-market model development

Related news

Blog April 17, 2023
Reimbursement of Rare Disease Drugs in Italy: Challenges and Hopes for the Future
When it comes to rare diseases, Italy has done a good job in bringing EMA-approved drugs, including orphan drugs, to the Italian market. But  multiple challenges exist, many of which(...)
Italy Market Access Pharma Rare Disease Real-World Evidence (RWE)
Blog April 17, 2023
Pharmaceutical Market Access in the UK: A Changing Landscape
Start reading this interview with Rachel Fyson to gain insight into the changing landscape of market access in the United Kingdom.
Market Access Pharma UK
Blog April 14, 2023
Lifecycle Optimization: The Path to Commercial Success
Pharmaceutical and biotech companies constantly focus on product innovation. But how can you also increase your effectiveness in order to be as commercially competitive and efficient as possible?
Market Access MedTech Pharma
News April 5, 2023
Alira Health Joins EMIG to Advance Market Access in the UK
We are pleased to announce that Alira Health has joined the Ethical Medicines Industry Group (EMIG), a multi-stakeholder network and trade association that represents the interests(...)
Market Access Patient Centricity UK
Blog March 20, 2023
The State of Market Access in Italy 2023
To learn about the state of market access in Italy today, we spoke with Giovanni Firenze, Director of Market Access Italy for Alira Health, who attended the recent 2023 Conferenza Nazionale(...)
Drug Development Italy Market Access Pharma
Events March 6, 2023
World EPA Congress 2023
We are pleased to share that we will be participating in World EPA Congress 2023 as speakers and sponsors. World Evidence, Pricing and Access Congress is Europe’s largest congress(...)
Biotech Market Access Pharma Real-World Evidence (RWE)
Blog March 6, 2023
Market Access in Catalonia: 2022 Trends and What’s Next
Alira Health contributed to the recently published 2022 BioRegion Report, the most extensive analysis of the assets, achievements, and trends in the life sciences and healthcare sector(...)
Biotech Market Access MedTech Spain
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.